Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Neogen (NEOG) Stock Price

Media stories about Neogen (NASDAQ:NEOG) have trended somewhat positive recently, according to Accern. The research group identifies negative and positive press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Neogen earned a media sentiment score of 0.03 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 45.5078150954154 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

Neogen (NASDAQ:NEOG) traded up $0.75 during trading hours on Tuesday, hitting $79.91. 89,503 shares of the company were exchanged, compared to its average volume of 110,992. The stock has a market cap of $3,097.41, a PE ratio of 68.13, a P/E/G ratio of 4.12 and a beta of 1.54. Neogen has a 1 year low of $59.51 and a 1 year high of $85.89.

Neogen’s stock is set to split before the market opens on Tuesday, January 2nd. The 4-3 split was announced on Friday, December 8th. The newly created shares will be payable to shareholders after the closing bell on Friday, December 29th.

Neogen (NASDAQ:NEOG) last posted its quarterly earnings data on Tuesday, September 19th. The company reported $0.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.30 by $0.01. The firm had revenue of $95.30 million during the quarter, compared to analysts’ expectations of $94.87 million. Neogen had a net margin of 12.28% and a return on equity of 9.93%. The firm’s quarterly revenue was up 14.0% on a year-over-year basis. During the same quarter last year, the company posted $0.26 EPS. analysts forecast that Neogen will post 1.31 EPS for the current year.

Several analysts have recently weighed in on the stock. Zacks Investment Research cut shares of Neogen from a “buy” rating to a “hold” rating in a research note on Friday, August 18th. Craig Hallum increased their price target on shares of Neogen from $62.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, December 7th. Roth Capital initiated coverage on shares of Neogen in a research report on Tuesday, December 5th. They set a “neutral” rating and a $82.00 price objective for the company. Finally, BidaskClub cut shares of Neogen from a “buy” rating to a “hold” rating in a research report on Friday, August 18th. Five research analysts have rated the stock with a hold rating, The stock has a consensus rating of “Hold” and an average price target of $85.00.

In related news, VP Edward Bradley sold 38,876 shares of the stock in a transaction that occurred on Wednesday, September 20th. The shares were sold at an average price of $71.28, for a total transaction of $2,771,081.28. Following the completion of the transaction, the vice president now owns 83,712 shares of the company’s stock, valued at approximately $5,966,991.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider James L. Herbert sold 26,000 shares of the stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $81.45, for a total transaction of $2,117,700.00. Following the transaction, the insider now directly owns 879,430 shares of the company’s stock, valued at approximately $71,629,573.50. The disclosure for this sale can be found here. Insiders have sold a total of 173,034 shares of company stock valued at $13,316,509 in the last ninety days. 4.20% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: “Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Neogen (NEOG) Stock Price” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/12/12/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-neogen-neog-stock-price.html.

About Neogen

Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.

Insider Buying and Selling by Quarter for Neogen (NASDAQ:NEOG)

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply